Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...
Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...
Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S.
Jefferson Parish is using opioid settlement money for a new drug court. Is it the best use of funds?
Jeffrey Alford had been living in active addiction for five years when, in August 2020, he was arrested on a felony charge of possession of a Schedule II drug and booked at the Jefferson Parish jail.
The Food and Drug Administration on Wednesday rubber-stamped a new drug to treat pancreatic cancer and substantially extend the lives of patients. The drug, daraxonrasib, is produced by Revolution ...
The typical price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting rising costs ...
The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. By Carolyn Y. Johnson Many people have a cartoonish idea of narcolepsy, perhaps picturing someone ...
Please provide your email address to receive an email when new articles are posted on . The new drug application included data from the phase 3 ADVANCES OUTCOMES trial. The Prescription Drug User Fee ...
Efforts to bring down Scotland's sky-high rate of drug deaths are being frustrated by the arrival of hundreds of powerful new synthetic substances that experts warn are making the deadly drugs crisis ...
An update to this study of ICER has been published here, thanks to conversation with and insight from Mitchell Stein, policy and communications director at ICER, who clarified the differences between ...
The reliable supply of drugs is fundamental to any healthcare system, yet shortages remain a persistent problem. Disruptions arise from a range of causes: manufacturing failures, fluctuating demand, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results